If you are reacting to market conditions, you are already late.
The market’s story about Robinhood Ventures is a mania story — a fund that opened at $25 in March, ran to $73.71 by mid-May on nothing but scarcity, and gave all of it back by late July. That’s the backward-looking read, and it’s the one most people still carry.
The forward-looking read is different. The mania is over. What’s left is a pair of listed vehicles doing something genuinely new — putting OpenAI, SpaceX, Anthropic, Stripe, and Databricks into an ordinary brokerage account with no accreditation letter — now trading close enough to what they hold to underwrite seriously. The transition isn’t hype to bust. It’s a scarcity trade becoming an asset trade, and that’s a far better business to be in.
This is Part 2 of a two-part series.
Sunday Dinner
Eleven Miles from Palo Alto
·
Aug 16
There were too many people for the table, so the younger cousins ate standing up with their plates balanced on the arm of the couch. Lola Purisima turned seventy-five on a Sunday in August, and the fog had come in over the ridge the way it does in Daly City, so the windows were sweating and somebody had propped the front door open with a shoe.
What We’re Looking At — A closed-end fund holding a concentrated book of late-stage private companies: OpenAI, Databricks, Stripe, Revolut, Ramp, plus a small public SpaceX stake taken at its June IPO.
Our Recommendation — Accumulate, in tranches, toward net asset value. Not at the premium.
How We Feel (Sentiment) — Constructive but unhurried. The scarcity bid is gone and hasn’t come back.
Current Price — ~$28.56 (Aug 14 close)
Net Asset Value — $25.02 (June 30 mark) — a ~14% premium
The Buy Zone — $26.50–$28.00 core; add $24.50–$26.00 near NAV
Our 1-Year Target — $38.00 (+35%)
Our Safety Net (Stop-Loss) — $22.00
Expected Price Swing — Options imply ~85–90% annualized movement, against ~63% actually realized
What We’re Looking At — A business development company holding ~80 early-stage startups, each connected to Y Combinator, at roughly 1.12% apiece. Largest position Tasklet at ~4.5%; about 7.4% in cash.
Our Recommendation — Accumulate on the post-IPO fade, while it’s still below the offer.
How We Feel (Sentiment) — Cautiously positive. A debut below the offer price is a healthier starting line than RVI ever got.
Current Price — $24.45 (Aug 14 close), still −2.2% versus the $25.00 IPO
Estimated Post-Load Fair Value — ~$23.88 (first official NAV not yet published)
The Buy Zone — $23.50–$24.50 now; add $22.00–$23.00 on a retest of the debut low
Our 1-Year Target — $32.00 (+31%)
Our Safety Net (Stop-Loss) — $18.00
Expected Price Swing — No listed options yet, so there is no implied number. Two sessions of tape is all we have.
Go looking for a P/E on either of these and you won’t find one — nor revenue growth, gross margin, insider selling, short interest, or a Wall Street target. There is no analyst coverage on either fund. That’s not a red flag; it’s a category difference, and it’s worth ninety seconds.
An operating company earns money, so you value it on earnings. A fund holds things, so you value it on what it holds. Two numbers matter:
Net Asset Value (NAV) — everything inside, divided by shares. What it’s worth.
Price — what someone will pay you today. What it costs.
For most funds those sit on top of each other. For a fund holding something scarce, they come apart, and the gap has a name: above NAV is a premium, below is a discount. When RVI traded at $73.71 against roughly $25 of holdings, buyers weren’t paying for OpenAI. They were paying for the only way in. When SpaceX listed in June, the only way in stopped being the only way in — the premium evaporated and the assets never moved.
In plain English: buy a fund at a big premium and you own two bets, the assets and the mood. You can research the first. You cannot research the second.
One more line public-company investors never think about: fees compound against you. RVI runs 2.72%. RVII is worse — a 4.50% sales load, then ~4.18% in first-year expenses including 2% management and 20% of profits. On flat marks that isn’t a neutral year. It’s a slow leak.
The Avokado Decision Tree® is a structured framework for making smart, consecutive financial choices. Built on classical economic theory and data science, it acts as a filter for your capital by asking three simple, consecutive questions: First, do you save? Then, do you invest? Finally, are you being entrepreneurial? The more you make good, consecutive decisions, the larger your financial security grows over time.
1. Save: Is there a financial safety net? Unusually, yes — for an unusual reason. Neither fund carries the debt a growth company would: no interest bill, no refinancing cliff. RVI held $347.1M in money market funds — 53% of net assets — as of its March schedule, dry powder waiting for the right round. RVII holds ~7.4% cash. The threat here isn’t leverage; it’s the expense ratio quietly eating the base.
2. Invest: Is the business getting more profitable? Wrong question for a fund. The right one is whether NAV compounds — and RVI’s went $24.42 at inception, $24.05 in March, $25.02 by June 30. Roughly flat, and flat is not what 2.72% is for. This rests on future mark-ups, not demonstrated ones. RVII hasn’t published a NAV at all yet.
3. Be Entrepreneurial: What is the big growth spark? Here’s where the thesis lives. RVI put roughly $75M into OpenAI common stock in April — its largest position — and took a $6.75M SpaceX IPO allocation in June, alongside Canva and Whatnot. RVII is the opposite shape: 80 seed-stage Y Combinator companies, near-equally weighted, betting on the power law that one or two names carry the book. Robinhood has funds three through six planned. If that flywheel works, the durable asset is access to the deal flow — not any single holding.
The premium can vanish again, and it needs no bad news to do it. RVI already proved this once. Anthropic or OpenAI listings would raise NAV while crushing what people pay above it — the share price can fall while the fund gets richer.
The marks are estimates. Both hold Level-3 assets, valued off the last funding round rather than a live market. Those lag reality by quarters, in either direction. NAV is a considered opinion, not a quote.
Most seed companies fail. Not a knock on RVII — it’s the arithmetic of the asset class. Eighty names helps; it doesn’t guarantee the winners cover the losers after a 20% carry.
Liquidity runs one direction. Both funds trade daily. Their holdings don’t. In a panic the fund sells instantly and the portfolio can’t — exactly when discounts get ugly. RVII’s tape is thin already: 2.35M shares on debut, 0.77M on day two.
The conflicts are disclosed and real: Robinhood is both adviser and selling shareholder, and Y Combinator does not sponsor, manage, or endorse RVII.
Only RVI has a listed chain. RVII has none — no implied volatility, no open interest, no max pain, nothing. Any risk control on RVII is position sizing and the $18 stop. We’d rather say that than pretend the data exists.
On RVI, the tell worth reading is the Put/Call Open Interest Ratio.
⚡ The Concept: Put/Call Ratio. Every option is a call (upside exposure) or a put (downside protection). Divide puts by calls and you get a crude but useful gauge of how positioning is skewed. Below 1.0, calls outnumber puts and the crowd leans up. Above 1.0, puts dominate — more money is buying protection than upside. It’s sentiment, not prediction, and it’s most useful when the number is stretched or when it changes shape across expirations.
RVI’s does exactly that. August open interest sits near 1.07 — balanced. December sits at 1.83, roughly 3,974 puts against 2,170 calls, with the heaviest single strike being the $25 put. Traders are calm about the next few weeks and buying year-end insurance clustered precisely at NAV.
That’s the same conclusion the fundamentals reach by another road: the market treats $25 as the floor that matters — which is why our adds sit near it rather than above it.
Two cautions. The chain is thin, roughly 1,500–4,000 contracts per expiry with wide spreads on the wings, and thin chains gap. And with implied volatility near 85–90% against 63% realized, premium here is expensive relative to how much the fund actually moves — favoring defined-risk spreads over naked calls. TastyTrade‘s chain display makes the volume-versus-open-interest distinction easy to see if you’re studying the mechanics.
Because the market moves in predictable economic cycles, buying your entire position all at once near recent highs is a recipe for regret. Instead, we use a three-part accumulation strategy to spread risk over several milestones.
With two funds, the weighting is the decision — and we deliberately overweight the one trading closer to fair value, because that’s the whole thesis here:
Part 1 ($6,000 — the core, split): $3,500 into RVII at $23.50–$24.50 (~145 shares), still below its own IPO price. $2,500 into RVI at $26.50–$28.00 (~90 shares) — the smaller slice, precisely because you’re paying ~14% over NAV for it.
Part 2 ($2,500 — the patient add): Resting limit orders at RVII $22.00–$23.00 (retest of the debut low) and RVI $24.50–$26.00 (at or near the June NAV mark). Fill whichever comes to you. Chase neither.
Part 3 ($1,500 — capitulation only): RVII $18.00–$21.00 or RVI $22.00–$24.00, and only if NAV holds while the price falls. A discount to a stable NAV is an opportunity; a discount to a collapsing one is a trap.
Our Emergency Exit: RVI below $22.00. RVII below $18.00. Sustained trade beneath those levels, paired with deteriorating marks, means the thesis is wrong — not early. Take the loss, keep the rest of the capital.
One rule matters more than the tranches: don’t add to either fund if the premium re-expands past 25–30% without a fresh NAV print justifying it. That single discipline would have saved Part 1’s Joaquin most of his loss.
This is what managing your own money buys you. Nobody sends you a quarterly letter explaining away a 14% premium you chose to pay. You look at the number, you own the decision, you get better. That accountability is the edge — not access to a fund.
This playbook isn’t built on gut feelings, rumors, or social media hype. Every asset we look at is processed through a strict, customized model engineered to evaluate it across 12 rigorous pillars. Before a single dollar of our capital is deployed, our rules system stress-tests the macro environment, regulatory exposures, true balance sheet health, competitive peer metrics, and hidden institutional options data. We do the deep data digging so that you get a clear, high-signal game plan.
The numbers above are the surface. The full fee-drag arithmetic, complete holdings schedules, peer comparisons against ARCC and HTGC, and detailed technical timelines are in the source documents.
This piece draws on two: Robinhood Ventures Fund I (RVI) — Investment Research Report and Robinhood Ventures Fund II (RVII) — Investment Research Report, the latter refreshed August 15, 2026 with the first two sessions of post-IPO tape.
How to get the reports:
Simply click “Message” below to request the secure PDF, and it will be sent directly to your inbox.
Disclaimer: This brief is for informational and educational purposes only. Capital preservation is priority one. Trading options and small-cap growth stocks involves a substantial risk of loss. Always perform your own research before investing.
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.